Common Equity: The sum of all common equity items.
Adverum Biotechnologies, Inc. (ADVM) had Common Equity of $26.42M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-47.02M |
|
-- |
|
-- |
|
$48.22M |
|
$-48.22M |
|
$1.20M |
|
$-47.02M |
|
$-47.02M |
|
$-47.02M |
|
$-47.02M |
|
$-47.02M |
|
$-47.02M |
|
$-48.22M |
|
$-47.97M |
|
20.94M |
|
20.94M |
|
$-2.25 |
|
$-2.25 |
|
| Balance Sheet Financials | |
$89.47M |
|
$11.13M |
|
$48.19M |
|
$137.65M |
|
$25.09M |
|
-- |
|
$86.14M |
|
$111.23M |
|
|
Common Equity |
$26.42M |
$26.42M |
|
$26.42M |
|
20.89M |
|
| Cash Flow Statement Financials | |
$-42.77M |
|
$31.28M |
|
-- |
|
$62.63M |
|
$51.14M |
|
$-11.49M |
|
$2.78M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.57 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-42.99M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-177.95% |
|
-177.95% |
|
-34.16% |
|
-177.95% |
|
$1.26 |
|
$-2.05 |
|
$-2.04 |
|